HCA Healthcare Management
Management criteria checks 2/4
HCA Healthcare's CEO is Sam Hazen, appointed in Jan 2019, has a tenure of 6.33 years. total yearly compensation is $21.32M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth $443.41M. The average tenure of the management team and the board of directors is 6 years and 9 years respectively.
Key information
Sam Hazen
Chief executive officer
US$21.3m
Total compensation
| CEO salary percentage | 7.1% |
| CEO tenure | 6yrs |
| CEO ownership | 0.5% |
| Management average tenure | 6yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
HCA Healthcare's (NYSE:HCA) Dividend Will Be Increased To $0.72
Jan 27
HCA Healthcare Q4 Earnings Recap: Overreaction To One-Time Event
Jan 24Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jan 12HCA Healthcare: Sentiment Has Swung Too Negative
Dec 29We Think HCA Healthcare (NYSE:HCA) Can Stay On Top Of Its Debt
Dec 26Shareholders Would Enjoy A Repeat Of HCA Healthcare's (NYSE:HCA) Recent Growth In Returns
Nov 10HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)
Oct 22HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing
Oct 16HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price
Oct 01HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation
Sep 28Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Sep 16Does HCA Healthcare (NYSE:HCA) Have A Healthy Balance Sheet?
Sep 01Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?
Jun 21HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
Jun 06Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
May 21HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare Continues To Impress
Dec 14HCA Remains Attractive Despite A JV Misstep
Nov 20HCA Healthcare: Rx For Success
Oct 10HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30HCA Healthcare Is Beating The Industry
Sep 13HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | US$6b |
| Sep 30 2024 | n/a | n/a | US$6b |
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$5b |
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$15m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$7b |
| Dec 31 2021 | US$21m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$5b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$30m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$27m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$10m | US$1m | US$4b |
Compensation vs Market: Sam's total compensation ($USD21.32M) is above average for companies of similar size in the US market ($USD12.63M).
Compensation vs Earnings: Sam's compensation has increased by more than 20% in the past year.
CEO
Sam Hazen (64 yo)
6yrs
Tenure
US$21,315,984
Compensation
Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 6yrs | US$21.32m | 0.52% $ 443.4m | |
| Executive VP & COO | 2yrs | US$8.70m | 0.073% $ 61.9m | |
| President of American Group | 12yrs | US$5.40m | 0.050% $ 42.6m | |
| President of National Group | 8.5yrs | US$5.58m | 0.011% $ 9.0m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 160.3m | |
| CFO & Executive Vice President | less than a year | no data | 0.028% $ 23.3m | |
| Senior VP | 8.8yrs | no data | 0.016% $ 13.5m | |
| Senior VP & Chief Information Officer | less than a year | no data | 0.00062% $ 525.5k | |
| Executive VP and Chief Legal & Administrative Officer | 3yrs | US$6.47m | 0.0016% $ 1.3m | |
| Vice President of Investor Relations | 3yrs | no data | no data | |
| Senior VP and Chief Ethics & Compliance Officer | 6yrs | no data | 0.0037% $ 3.2m | |
| Senior Vice President of Marketing & Corporate Affairs | 7.3yrs | no data | 0.0014% $ 1.2m |
6.0yrs
Average Tenure
60yo
Average Age
Experienced Management: HCA's management team is seasoned and experienced (6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 6.3yrs | US$21.32m | 0.52% $ 443.4m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 160.3m | |
| Independent Director | 7yrs | US$389.78k | 0% $ 0 | |
| Independent Director | 10.9yrs | US$377.95k | 0.0016% $ 1.4m | |
| Independent Director | 10.9yrs | US$334.78k | 0.0080% $ 6.7m | |
| Chairman of the Board | 19yrs | US$399.61k | no data | |
| Independent Director | 5.8yrs | US$319.78k | 0.0025% $ 2.1m | |
| Independent Director | 3.3yrs | US$339.78k | 0.0010% $ 881.5k | |
| Independent Director | 13yrs | US$349.78k | 0.0043% $ 3.6m | |
| Director | 16yrs | US$309.70k | 0.16% $ 135.8m | |
| Independent Director | 3yrs | US$324.78k | 0.0014% $ 1.2m | |
| Director of HealthONE | no data | no data | no data |
9.0yrs
Average Tenure
65yo
Average Age
Experienced Board: HCA's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 23:01 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HCA Healthcare, Inc. is covered by 46 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |